Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Operating Expenses | 8,754 | 11,715 | 19,484 | 18,300 | 18,940 |
| Operating Income | -8,754 | -11,715 | -19,484 | -18,300 | -18,940 |
| Interest Expense | 0 | -292 | 419 | 172 | 209 |
| Other Income | 98 | -470 | 0 | 0 | 0 |
| Pre-tax Income | -8,656 | -11,893 | -19,903 | -18,472 | -19,149 |
| Income Tax | -748 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -7,908 | -11,893 | -19,903 | -18,472 | -19,149 |
| Net Income Discontinuous | 22,667 | 4,117 | 25,155 | 3,104 | 3,549 |
| Net Income | $14,759 | $-7,776 | $5,252 | $-15,368 | $-15,600 |
| EPS Basic Total Ops | 0.45 | -0.25 | 0.17 | -0.48 | -0.49 |
| EPS Basic Continuous Ops | -0.24 | -0.37 | -0.63 | -0.58 | -0.60 |
| EPS Basic Discontinuous Ops | 0.69 | 0.12 | 0.80 | 0.10 | 0.11 |
| EPS Diluted Total Ops | 0.45 | -0.25 | 0.17 | -0.48 | -0.49 |
| EPS Diluted Continuous Ops | -0.24 | -0.37 | -0.63 | -0.58 | -0.60 |
| EPS Diluted Discontinuous Ops | 0.69 | 0.12 | 0.80 | 0.10 | 0.11 |
| EBITDA(a) | $-8,627 | $-11,535 | $-18,971 | $-17,841 | $-18,459 |